Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Former FBI Director Robert Mueller has Parkinson’s disease: report

by admin September 1, 2025
September 1, 2025
Former FBI Director Robert Mueller has Parkinson’s disease: report

Former FBI Director Robert Mueller was diagnosed with Parkinson’s disease, his family revealed to the New York Times.

Mueller is the former special counsel who led the Russia investigation into President Donald Trump’s 2016 campaign.

Mueller, 81, was diagnosed in 2021 and retired from public life the following year after briefly teaching law, according to a family statement provided to The Times.

‘Bob was diagnosed with Parkinson’s disease in the summer of 2021. He retired from the practice of law at the end of that year. He taught at his law school alma mater during the fall of both 2021 and 2022, and he retired at the end of 2022,’ the statement said.

This post appeared first on FOX NEWS

previous post
Commencement of Henbury Field Program
next post
Trump says he will require voter ID with executive order

Related Posts

US accuses Denmark of treating Greenlanders as ‘second-class...

March 29, 2025

Zelenskyy says peace deal is close after Trump...

December 30, 2025

‘It’s a joke’: White House dismisses ‘No Kings’...

October 21, 2025

Pakistan declares ‘open war’ on Afghanistan in response...

February 27, 2026

Ex-judges blast top Trump DOJ official for declaring...

November 15, 2025

Why Trump, rightly praised for the Gaza ceasefire,...

October 16, 2025

Trump delivers ultimatum to Hamas: Accept deal and...

September 8, 2025

House Republicans push Johnson to go to war...

March 2, 2026

Mamdani’s ‘gun violence’ comments after killing of 7-month...

April 4, 2026

From Gaza to Iran: What’s at stake in...

December 29, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved